Check out updates to COVID-19 management guideline!

Makeda Semret
Feb 10, 2021
1 min read

Our guideline working group has reviewed latest evidence and recommends therapeutic anticoagulation (instead of prophylactic) for mild and moderate COVID-19. This is based on review of latest evidence from 3 international trials, demonstrating marked benefit (net benefit in terms of organ-support free days, irrespective of D-dimer levels). No benefit (and possible harm) for severe COVID-19. Endorsed by MUHC P&T committee!

Recent Posts

See All

Update: Empiric Management of Urethritis, Prostatitis, and Epididymo-orchitis guidelines

The ASP group is pleased to announce the publication of the Empiric Management of Urethritis, Prostatitis, and Epididymo-orchitis guidelines. This resource provides a concise overview of clinical mani

MUHC ASP annual report 2024-2025

The ASP chairs are happy to publish the MUHC ASP annual report 2024-2025, now available in the Resources section of the MUHC ASP website. The report contains several key information and analysis on th

AMR Awareness Week Post

Comments